Role of tracheal stent in esophageal cancer-induced esophagotracheal fistula complicated with pulmonary infection
占丰富,黄茂宏,曾惠清,杜艳萍,陈怡园,张孝斌
DOI: https://doi.org/10.3760/cma.j.cn131368-20220501-00341
2022-01-01
Abstract:Objective:To explore the clinical value of tracheal stent in esophageal cancer-induced esophagotracheal fistula complicated with pulmonary infection.Methods:This was a case-control study.The clinical data of 26 patients with esophageal cancer-induced esophagotracheal fistula complicated with pulmonary infection who didn′t receive esophageal stents in the Department of Pulmonary and Critical Care Medicine in Zhongshan Hospital, Xiamen University from October 2019 to January 2022 were analyzed by non-random sampling method.Among them, 16 patients, who were placed with tracheal stent under the real-time guidance of electronic bronchoscope on the basis of nasojejunal tube placement, were included in the tracheal stent combined with nasojejunal tube group; the remaining 10 patients, who gave up tracheal stent and only received the nasojejunal tube, were included in the simple nasojejunal tube group.The life quality, symptoms, inflammatory indexes, and imaging changes of the two groups were observed.Results:The sixteen patients in the tracheal stent combined with nasojejunal tube group were successfully implanted with 6 metal covered stents, 4 straight-tube silicone stents, and 6 Y-shaped silicone stents.The Karnofsky (KPS) score of patients after stent placement was significantly higher than that before stent placement ( P<0.05). Meanwhile, the white blood cell count, neutrophil count, C-reactive protein, procalcitonin, and CT scores were significantly lower than those before stent placement (all P<0.05). The KPS score in patients with simple nasojejunal tube placement was significantly higher than that before implantation ( P<0.05). Meanwhile, the white blood cell count, neutrophil count, C-reactive protein, procalcitonin, and CT scores were significantly lower than those before implantation (all P<0.05). There was no significant difference in KPS score, white blood cell count, neutrophil count, C-reactive protein, procalcitonin, and CT score between the two groups before the implantation of nasojejunal tube and tracheal stent (all P>0.05). There was no significant difference in KPS score, white blood cell count, neutrophil count, and 3-month survival rate between the two groups after implantation (all P>0.05). Compared with the patients with simple nasojejunal tube implantation, the patients with the implantation of tracheal stent and nasojejunal tube had lower level of C-reactive protein, procalcitonin, and CT scores, and the time required for cough improvement and temperature returning to normal were shorter (all P<0.05). Conclusions:The implantation of tracheal stent and nasojejunal tube has a significant therapeutic effect on patients with esophageal cancer-induced esophagotracheal fistula complicated with pulmonary infection.It can improve patient′s quality of life, relieve the symptoms, and help to treat aspiration pneumonia.This approach should be widely adopted in clinical practice.